JUNOVAN Trademark

Trademark Overview


On Tuesday, September 13, 2005, a trademark application was filed for JUNOVAN with the United States Patent and Trademark Office. The USPTO has given the JUNOVAN trademark a serial number of 79020936. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, September 13, 2015. This trademark is owned by I.D.M. IMMUNO-DESIGNED MOLECULES. The JUNOVAN trademark is filed in the Pharmaceutical Products category with the following description:

Preparations for medical or veterinary use, namely muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), N-acetylmuramyl-L-ananyl-D-isoglutaminyl-L-alanine-2 (l,2-dipalmitoyl-sn-glycero-3-hydroxyphosphoryloxy) ethylamide, hexopyranose and formulations of muramyl peptides, particularly liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, pharmaceutically acceptable salts of muramyl peptides, all these goods specifically used for cancer control treatment, antiviral treatment, neoplasia and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy; pharmaceutical preparations for anti-cancer and antiviral therapies, neoplasia and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy
junovan

General Information


Serial Number79020936
Word MarkJUNOVAN
Filing DateTuesday, September 13, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, September 13, 2015
Registration Number3177316
Registration DateTuesday, November 28, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2006

Trademark Statements


Goods and ServicesPreparations for medical or veterinary use, namely muramyl peptides and muramyl tripeptides, muramyl tripeptide phosphatidyl ethanolamine (MTP-PE), N-acetylmuramyl-L-ananyl-D-isoglutaminyl-L-alanine-2 (l,2-dipalmitoyl-sn-glycero-3-hydroxyphosphoryloxy) ethylamide, hexopyranose and formulations of muramyl peptides, particularly liposomal formulations, pharmaceutically acceptable forms of muramyl peptides, pharmaceutically acceptable salts of muramyl peptides, all these goods specifically used for cancer control treatment, antiviral treatment, neoplasia and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy; pharmaceutical preparations for anti-cancer and antiviral therapies, neoplasia and pathologies induced by chemotherapy, particularly mucositis, myelosuppression, peripheral neuropathy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 4, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameI.D.M. IMMUNO-DESIGNED MOLECULES
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameI.D.M. IMMUNO-DESIGNED MOLECULES
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameI.D.M. IMMUNO-DESIGNED MOLECULES
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, April 19, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, April 19, 2018DEATH OF INTERNATIONAL REGISTRATION
Saturday, June 6, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, December 20, 2014GENERIC MADRID TRANSACTION SENT TO IB
Saturday, December 20, 2014GENERIC MADRID TRANSACTION CREATED
Wednesday, June 4, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 4, 2013CANCELLED SECTION 71
Thursday, May 1, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 28, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, March 16, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 6, 2007FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 6, 2007FINAL DISPOSITION PROCESSED
Thursday, June 28, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 28, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, September 12, 2006PUBLISHED FOR OPPOSITION
Wednesday, August 23, 2006NOTICE OF PUBLICATION
Sunday, July 16, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, July 16, 2006ASSIGNED TO LIE
Monday, July 10, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 10, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 15, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 15, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 15, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 21, 2006REFUSAL PROCESSED BY IB
Thursday, March 30, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 29, 2006REFUSAL PROCESSED BY MPU
Tuesday, March 28, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 27, 2006NON-FINAL ACTION WRITTEN
Friday, March 24, 2006ASSIGNED TO EXAMINER
Friday, March 24, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, March 23, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB